FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss
FDA has warned consumers against using ‘compounded’ versions of semaglutide, the key ingredient found in Ozempic and Wegovy
FDA has warned consumers against using ‘compounded’ versions of semaglutide, the key ingredient found in Ozempic and Wegovy